Merrell is the division chief of neuro-oncology and associate professor of neurology at Vanderbilt University Medical Center.
May 25, 2025
Video
IDH inhibitors, now FDA approved for lower-grade gliomas, yield fewer side effects than chemotherapy, said Dr. Ryan Merrell.
This Wasn't the Plan: The Truth
Living With Intention After a Cancer Diagnosis
June Lung Cancer Highlights: Top 5 Updates Patients Should Know
Could Shedding a Few Pounds Prevent a Breast Cancer Recurrence?